Applied Financial Statements From 2010 to 2025

APDN Stock  USD 0.18  0.00  0.000006%   
Applied DNA financial statements provide useful quarterly and yearly information to potential Applied DNA Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Applied DNA financial statements helps investors assess Applied DNA's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Applied DNA's valuation are summarized below:
Gross Profit
851 K
Profit Margin
(2.14)
Market Capitalization
9.8 M
Enterprise Value Revenue
1.1011
Revenue
3.4 M
We have found one hundred twenty available fundamental signals for Applied DNA Sciences, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Applied DNA's prevailing fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 1st of February 2025, Market Cap is likely to drop to about 6.5 M. In addition to that, Enterprise Value is likely to drop to about 6.5 M

Applied DNA Total Revenue

4.78 Million

Check Applied DNA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied DNA's main balance sheet or income statement drivers, such as Interest Expense of 16 M, Other Operating Expenses of 14.2 M or Total Operating Expenses of 12.9 M, as well as many indicators such as Price To Sales Ratio of 0.82, Dividend Yield of 0.0855 or PTB Ratio of 52.8 K. Applied financial statements analysis is a perfect complement when working with Applied DNA Valuation or Volatility modules.
  
Check out the analysis of Applied DNA Correlation against competitors.

Applied DNA Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities3.8 M2.8 M2.6 M
Slightly volatile
Accounts Payable907.3 K1.3 M988.6 K
Slightly volatile
Common Stock Total Equity4.4 K4.6 K99.1 K
Slightly volatile
Common Stock Shares Outstanding4.8 M4.6 M962.5 K
Slightly volatile
Non Current Liabilities Total1.9 M1.3 M1.7 M
Slightly volatile
Other Stockholder Equity385 M366.6 M251.7 M
Slightly volatile
Total LiabilitiesM4.4 M4.3 M
Slightly volatile
Common Stock8.8 K9.3 K101.2 K
Slightly volatile
Other Current Liabilities1.1 M564.9 K743.8 K
Slightly volatile
Total Assets7.7 M14.7 M9.9 M
Slightly volatile
Cash7.8 M7.4 M5.2 M
Slightly volatile
Cash And Short Term Investments7.8 M7.4 M5.2 M
Slightly volatile
Liabilities And Stockholders Equity7.7 M14.7 M9.9 M
Slightly volatile
Total Current Assets5.2 M9.3 M7.3 M
Slightly volatile
Short and Long Term Debt Total632 K665.2 K1.3 M
Slightly volatile
Non Current Assets Total5.7 M5.5 M2.8 M
Slightly volatile
Property Plant And Equipment Net753.1 K1.5 MM
Slightly volatile
Current Deferred Revenue50.3 K52.9 K471.8 K
Pretty Stable
Non Currrent Assets Other905.6 K862.5 K461 K
Pretty Stable
Property Plant And Equipment Gross6.5 M6.2 M2.3 M
Slightly volatile
Net Receivables395.5 K416.3 K1.5 M
Pretty Stable
Other Current Assets530.1 K938.4 K607.7 K
Slightly volatile
Capital Surpluse248.3 M316.9 M243.1 M
Slightly volatile
Property Plant Equipment2.7 M2.6 M1.3 M
Slightly volatile
Other Assets84.6 K89.1 K187 K
Pretty Stable
Non Current Liabilities Other799.9 K763.5 K1.1 M
Slightly volatile
Long Term Debt Total1.1 M595.1 K753.1 K
Pretty Stable
Net Invested Capital7.7 M10.5 M7.2 M
Slightly volatile
Capital Stock9.2 K9.3 K19.4 K
Slightly volatile
Deferred Long Term Asset Charges87.8 K98.7 K107.6 K
Slightly volatile

Applied DNA Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses14.2 M20.1 M16.3 M
Slightly volatile
Total Operating Expenses12.9 M17.3 M14 M
Slightly volatile
Selling General Administrative10 M10.3 M12 M
Pretty Stable
Research Development4.3 M4.1 M2.7 M
Slightly volatile
Total Revenue4.8 M3.9 M5.5 M
Slightly volatile
Gross Profit1.1 M1.2 M3.1 M
Very volatile
Cost Of Revenue4.1 M2.8 M4.6 M
Very volatile
Interest Income150.7 K158.7 K1.4 M
Slightly volatile
Reconciled Depreciation832 K800.9 K717.7 K
Slightly volatile

Applied DNA Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities16.2 M15.4 M10 M
Slightly volatile
End Period Cash Flow8.7 M8.3 M5.4 M
Slightly volatile
Begin Period Cash Flow9.5 M9.1 M5.3 M
Slightly volatile
DepreciationM626.8 K717.4 K
Pretty Stable
Stock Based Compensation625.2 K658.1 K1.5 M
Pretty Stable
Issuance Of Capital Stock10.9 M15.4 M7.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.820.86877
Slightly volatile
Dividend Yield0.08550.08140.0299
Slightly volatile
Days Sales Outstanding42.0744.28131
Slightly volatile
Average Payables701738424.4 K
Slightly volatile
Stock Based Compensation To Revenue0.180.190.4703
Slightly volatile
Capex To Depreciation0.690.531.0266
Very volatile
Inventory Turnover6.484.956.0525
Slightly volatile
Days Of Inventory On Hand94.0276.2564.0609
Slightly volatile
Payables Turnover1.491.861.9756
Slightly volatile
Sales General And Administrative To Revenue3.093.2531.1929
Slightly volatile
Average Inventory323 K345.9 K397.6 K
Slightly volatile
Research And Ddevelopement To Revenue1.021.21.116
Slightly volatile
Capex To Revenue0.130.140.676
Slightly volatile
Cash Per Share0.110.114579.2188
Slightly volatile
Days Payables Outstanding193203965
Slightly volatile
Income Quality1.211.14950.8099
Slightly volatile
Intangibles To Total Assets0.350.240.164
Slightly volatile
Current Ratio3.173.022.8907
Pretty Stable
Receivables Turnover6.188.537.6873
Slightly volatile
Graham Number4.114.3305767
Slightly volatile
Capex Per Share0.110.128.875
Slightly volatile
Average Receivables264 K277.9 K1.5 M
Pretty Stable
Revenue Per Share0.740.7881.0095
Slightly volatile
Interest Debt Per Share0.20.2159.4812
Slightly volatile
Debt To Assets0.06310.06650.2621
Slightly volatile
Operating Cycle13794.33193
Slightly volatile
Days Of Payables Outstanding193203965
Slightly volatile
Ebt Per Ebit0.780.450.9875
Slightly volatile
Quick Ratio1.442.862.6822
Very volatile
Net Income Per E B T1.141.131.0237
Slightly volatile
Cash Ratio2.532.412.0076
Pretty Stable
Days Of Inventory Outstanding94.0276.2564.0609
Slightly volatile
Days Of Sales Outstanding42.0744.28131
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.840.931.0344
Slightly volatile
Fixed Asset Turnover2.93.056.7189
Pretty Stable
Debt Ratio0.06310.06650.2621
Slightly volatile
Price Sales Ratio0.820.86877
Slightly volatile
Asset Turnover0.430.240.5977
Very volatile
Gross Profit Margin0.320.340.6216
Slightly volatile

Applied DNA Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap6.5 M6.8 M21.7 M
Slightly volatile

Applied Fundamental Market Drivers

Cash And Short Term Investments6.4 M

Applied Upcoming Events

8th of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of December 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About Applied DNA Financial Statements

Applied DNA investors utilize fundamental indicators, such as revenue or net income, to predict how Applied Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue52.9 K50.3 K
Total Revenue3.9 M4.8 M
Cost Of Revenue2.8 M4.1 M
Stock Based Compensation To Revenue 0.19  0.18 
Sales General And Administrative To Revenue 3.25  3.09 
Research And Ddevelopement To Revenue 1.20  1.02 
Capex To Revenue 0.14  0.13 
Revenue Per Share 0.78  0.74 
Ebit Per Revenue(3.68)(3.86)

Pair Trading with Applied DNA

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Applied DNA Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied DNA's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Dna Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Dna Sciences Stock:
Check out the analysis of Applied DNA Correlation against competitors.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.82)
Revenue Per Share
2.202
Quarterly Revenue Growth
(0.73)
Return On Assets
(0.57)
Return On Equity
(0.76)
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.